Loading...
By Kelly Young
Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM
At the request of the FDA, scientists are studying how children metabolize the active ingredient in the adult laxative polyethylene glycol 3350 (PEG 3350; Miralax) and whether its use could be tied to incident psychiatric problems in children, the New York Times reports.
The laxative is given routinely (and sometimes daily) to constipated children, yet it has never been approved for long-term daily use, neither in adults nor children. The agency has received reports of obsessive-compulsive behavior, tics, and tremors among children taking PEG 3350 laxatives.
In addition, the FDA said it had tested eight batches of Miralax in 2008 and found small amounts of ethylene glycol and diethylene glycol, which are antifreeze ingredients, in all the batches. These were impurities from the manufacturing process, according to the agency. The testing was undertaken because many of the adverse events reported (e.g., acidic blood) were consistent with ingestion of ethylene glycol.
Comment
LINK(S):
New York Times story (Free)
Background: NEJM Journal Watch General Medicine summary on safety of chronic PEG 3350 use in children (Your NEJM Journal Watch subscription required)